GU Ventures uppdrag är att kommersialisera forskningsbaserade innovationer med kopplingar till Göteborgs universitet. Årligen skapas och utvecklas ett tiotal nya företag i inkubatorn som inleder sin kommersialiseringsresa och får sin första investering. MucoLife Therapeutics är ett av dem, vars grundare etablerade kontakt med GU Ventures och Forsknings- och innovationskontoret vid Göteborgs universitet. Med sin innovativa läkemedelskandidat MLT-001 adresserar företaget ett stort medicinskt behov som påverkar över 500 miljoner människor världen över.
Read MoreLast Monday, the West Swedish Incubators and their partner at this event, AstraZeneca BioVentureHub, invited their startup- and industry community to an exclusive session on ”Revenue and pricing models for value capture” with US professor Lidija Polutnik, visiting from Babson College, Boston.
Read MoreThe West Swedish Incubators and their partner at this event, AstraZeneca BioVentureHub, welcome business leaders and entrepreneurs to join this exciting session to get some new insights from the US through visiting professor Lidija Polutnik from Babson College, world famous for their entrepreneur and leadership educations.
Read MoreNanolyze, a Swedish company developing bioanalytical technology to study nanoparticles, has moved into the BioVentureHub at the heart of the AstraZeneca Gothenburg R&D site.
Read MoreProfundus, pioneers in eye diagnostics with high resolution retina imaging, is now moving from GU Ventures to Astra Zeneca BioVentureHub. The hub is in the middle of the Astra Zeneca building in Mölndal Gothenburg and is an open innovation eco system where growing life science companies and researchers are in the same place for better cooperation.
Read More